Byetta Linked to Cancer In Rat Studies
This bad news for consumers as well as bad news for Eli Lilly and Amlyn Pharmaceuticals. Recent studies have shown an increase of instances of thyroid cancer in rats treated with Byetta. It appears the drug may be following in the footsteps Novo Nordisk’s competing Victoza, which hold a similar warning. Granted, the Byetta dose
Read MoreFDA Considers 5 Year Limit on Fosamax Use
This is a long time coming. It is about time that the FDA is finally coming around to the notion that long-term use of bisphosphonates like Fosamax is just a bad idea. The simple fact is that the longer a person uses Fosamax, the greater the likelihood that he/she will suffer from a severe, disabling
Read MoreThe Michael Brady Lynch Firm Salutes the Fallen Heroes of 9/11
Today marks the 10-year anniversary of the 9/11 terrorist attacks. I think almost everyone can remember exactly what they were doing at the moment they heard that America was at war. Having been born and raised a youngster in New York City, the Twin Towers were always a magical sight to behold as both a
Read MoreLexapro Launched in Japan Despite Birth Defect Risks
This is Michael Brady Lynch, lead trial attorney at The Michael Brady Lynch Firm. I always find it baffling that even in the face of overwhelming evidence that a drug causes severe side effects that far outweigh the benefits of treatment, drug companies can push through an approval process with the pressure and influence of
Read MoreDePuy ASR Hip Recall Problems Get Worse
Regular readers of this blog will remember that when the DePuy ASR Hip recall was first announced on August 24, 2010, I predicted that the problems that prompted the recall were understated and would only get worse. Well, I was unfortunately right. I have a lot of experience with defective hips. My experience in hip
Read MoreBirth Defects Linked to Increased Risk of Brain Tumors
The results of an intensive study conducted at Lucile Packard Children’s Hospital in Palo Alto, California revealed that children born with birth defects were nearly four times more likely to suffer from primitive neuroectodermal tumors compared to normal children. Because birth defects or fetal death during pregnancy often involves some type of genetic abnormality, that
Read MoreSSRI Stroke Risk
Hopefully, by now, everyone should be aware of the overwhelming evidence pointing to the association of drugs like Lexapro, Celexa, Zoloft, Prozac, and Paxil with birth defects. Now, however, there is a new wrinkle in the SSRI safety profile. Depressed middle-aged and older women are at significantly increased risk of stroke according to a new
Read MoreConsumer Alert! Dilfucan Birth Defect Warnings
This is Michael Brady Lynch, lead trial attorney at The Michael Brady Lynch Firm. Recent studies have indicated that Diflucan, the popular medication used to treat yeast infections, has been associated with birth defects including congenital heart defects and cleft palate. Diflucan joins a growing list of medications such as Lexapro, Celexa, Zoloft, Prozac, Paxil,
Read MoreMultaq Safety Concerns Over Cardiovascular Injury and Liver Failure
Maltaq was approved by the FDA in July 2009 for the treatment of abnormal heart rhythms. Soon after entering the market, disturbing reports of liver failure were reported with the drug. More recently, the FDA has warned of association with severe, even life threatening, cardiovascular problems. I encourage all my readers to discuss these new
Read MoreConsumer Alert! Fosamax Linked to Esphogeal Cancer
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Another serious safety concern with Fosamax! Can this drug get any worse in terms of a safety profile? Today FDA Communications issued a warning derived from a study from the UK General Practice Database that users of Fosamax of three years
Read More